Bordeaux, Boston, May 23, 2016 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today announces that it has been granted 510(k) clearance in the United States and the CE Mark in Europe to market the new Jazz Claw®. Jazz Claw is an unmatched hybrid […]